[Jiaotaiwan improves brain glucose metabolism in a mouse model of Alzheimer's disease by activating the PI3K/AKT signaling pathway].
Jiaotaiwan may improve brain sugar use in Alzheimer's mice by activating a key cell survival pathway
AI simplified
Abstract
Treatment with Jiaotaiwan improved memory ability and increased hippocampal neuron counts in a mouse model of Alzheimer's disease.
- AD mouse models showed significant learning and memory impairments, alongside increased Aβ amyloid plaques in the brain.
- Fasting serum insulin levels were elevated, indicating insulin resistance, while key components of the insulin-PI3K/AKT pathway were reduced.
- Treatment with Jiaotaiwan and donepezil resulted in reduced Aβ amyloid plaques and increased neuronal counts in the hippocampus.
- Both treatments enhanced the expression of PI3K, AKT, and glucose transporters in brain regions associated with memory and learning.
AI simplified